De-Risking Innovation in Small Pharma and Biotech Clinical Research - Possible or Not?

Innovation in clinical operations is often deemed exclusive to big pharma, with seemingly endless budgets and resources. But what about biotech? Are they relegated to simply focusing on molecule development, devoid of innovation?

Panelists:
Meraf-1

Meraf Eyassu

Executive Director, Clinical Operations, Terns Pharmaceutical
Joann Peters-1

Joann Peters

Chief Operating Officer, Geneos Therapeutics
Erika-1

Erica Talbott

Head of Customer and Site Success, Yonalink
Lauren-1

Lauren Briggs

SVP Customer Success, ProofPilot
Joseph Kim-1-1

Joseph Kim

Chief Strategy Officer, ProofPilot
Erin Boyle-1

Erin O'Boyle

VP, Clinical Operations, Rezolute, Inc.

iStock
image 8
attachment (3) 1
image 7
image 10
Group 3a02